Overview
Tarmo Annilo practices practicing medicine in Tartu, Estonia.
Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Hemochromatosis, and Atopic Dermatitis.
They are actively involved in clinical research, co-authoring 24 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tarmo Annilo
Is Tarmo Annilo a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Tarmo Annilo is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tarmo Annilo participate in research or clinical trials?
Yes. Tarmo Annilo has published 24 articles and abstracts on conditions like Lung Cancer. You can view a list of Tarmo Annilo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Atopic DermatitisAnnilo isExperienced. Learn about Atopic Dermatitis.
- HemochromatosisAnnilo isExperienced. Learn about Hemochromatosis.
- Hepatocerebral DegenerationAnnilo isExperienced. Learn about Hepatocerebral Degeneration.
- Lung CancerAnnilo isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)